Lydie Pani is an Endocrinology/Metabolic physician affiliated with Tufts University. OpenAlex indexes 21 publications with 816 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St # 408
Massachusetts General Hospital
Boston, MA 021142621
Telephone
617-726-3966Registry record last updated 6 Oct 2008.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
45.6%GLP-1 receptor agonist14.9%Ozempic44%Trulicity31%Mounjaro21%Rybelsus2%Wegovy2%Part D<11 patientsBiguanide (metformin)9.8%Metformin Hcl Er56%Metformin Hcl44%Part D≥96 patients+ 8 more classes in this area
Musculoskeletal
40.7%RANK Ligand Inhibitor40.7%Denosumab100%Part B, office-administered≥24 patientsHormonal (systemic)
11.5%l-Thyroxine10.3%Levothyroxine Sodium90%Synthroid10%Part D≥127 patientsThyroid Hormone Synthesis Inhibitor0.9%Methimazole100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2008–2008 per NIH RePORTER. The latest:
- Predictors and limitations of metformin as the initial agent in type 2 diabetes.
Massachusetts General Hospital
FY2008$58,886F32DK080631
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Protein Energy Malnutrition Is Associated with Worse Outcomes in Sepsis—A Nationwide Analysis
Journal of the Academy of Nutrition and Dietetics
2019 - Inferior Outcomes of Patients With Acute Myocardial Infarction and Comorbid Protein‐Energy Malnutrition
Journal of Parenteral and Enteral Nutrition
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Mohammad Almeqdadi
Tufts University
Natalie Nierenberg, MD
Tufts University
Lesley Inker, MD
Tufts University
Nadia Waheed, MD
Tufts University
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”